New study conducted on 18 people who have received Covaxin and Covishield (two different vaccines), concluded better protection.

TOP INSIGHT
Getting vaccinated with a combination of an adenovirus vector platform-based vaccine, followed by inactivated whole virus vaccine was not only safe but also produced better immunogenicity.
Read More..
The study titled ‘Serendipitous Covid-19 Vaccine-Mix in Uttar Pradesh, India: Safety and Immunogenicity Assessment of a Heterologous Regime’ has been uploaded on medRxiv.
The reaction of subjects was compared to 40 recipients of two doses of Covishield and 40 recipients of two doses of Covaxin.
All studies are in favour of mixing two vaccines to increase the protection against future infection. The subject expert committee of the Central Drugs Standard Control Organization has recommended a trial of mixing Covishield and Covaxin, which will be conducted by the Christian Medical College in Vellore on 300 healthy volunteers.
The ICMR's study was based on the goof-up that took place in May. There was no immediate adverse impact of the mix-up of the beneficiaries.
Mixing vaccines could be sensitive as World Health Organization has warned that individuals should not decide on mixing vaccines.
Source-Medindia
MEDINDIA

Email






